Novo Nordisk... By Emma Farge GENEVA (Reuters) -China, Qatar, Switzerland and others pledged over $170 million for the World Health Organization ...

The Novo Nordisk Foundation is not a charitable organisation ... But it does illustrate how the Foundation’s position at the top of the org chart allows it to keep its long-term, societal ...

Correctional officers often dictate end-of-life care for incarcerated people who are terminally ill. Most states either don’t have a formal policy or are given leeway — a big concern for families and ...

Years before Novo Nordisk's obesity drug Wegovy became a U.S. blockbuster, then-CEO Lars Rebien Sorensen told a press ...

A lot went wrong for Novo Nordisk A/S in the last six months, and a lot went right for competitor Eli Lilly. Novo Nordisk's competitive positioning in the obesity market has worsened, but I ...

Lars Rebien Sørensen, who chairs the Novo Nordisk Foundation, will join its board as an observer while the company seeks a ...

Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...

Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its ...

Novo Nordisk now expects sales to increase 13% to 21% for the year, down from a prior forecast of 18% to 26%. It also cut its operating profit growth forecast to 16% to 24% at constant exchange ...

With the agreement, the Foundation expands its existing collaboration with WHO, committing to a granting frame of up to DKK ...

Reuters reports that the World Health Organization is ready to recommend Zepbound and Wegovy as treatments for weight loss -- globally. Novo Nordisk's total addressable market for GLP-1 drugs ...

Novo Nordisk’s new top executive will need to help the company close the gap with Eli Lilly, fend off emerging rivals and ...